National Data and Statistical Center

Rocky Mountain Regional Brain Injury System

The Rocky Mountain Regional Brain Injury System (RMRBIS) conducts two site specific research projects, participates in three collaborative research modules, contributes to the longitudinal TBI National Database, and maintains a TBI Model System of care and research.

Research Project R1: Atomoxetine (Strattera) for the treatment of attention disorders in individuals with TBI determines if the only drug approved for attention deficit hyperactivity disorder in adults improves attention, behavioral functioning, and depression in individuals with TBI, using a randomized double-blind placebo-controlled crossover study design.

Research Project R2: A health and wellness intervention for individuals with TBI evaluates a specific, replicable small-group educational approach to improve health promoting behaviors, health-related self-efficacy, and health-related quality of life in individuals with TBI using a randomized wait list control group study design. If effective, this intervention could improve the health and wellness of the many people with secondary conditions and less than healthy lifestyles after TBI.

Collaborative Module 1: Sexuality after TBI examines the frequency, type, and severity of changes in sexual function associated with TBI.
Collaborative Module 2: Natural history of headache after TBI investigates incidence, prevelance, and types of headache after TBI.
Collaborative Module 3: Enhancing Core dataset to expand research on environmental influences affecting outcomes from TBI evaluates the feasibility, reliability, and utility of recording geographic identifiers for place of residence after TBI.